Rare Disease
Latest News
August 14th 2026
Rituximab biosimilars showed no significant 6-month differences vs the originator in antineutrophil cytoplasmic antibody–associated vasculitis (AAV).
More News
Switching to CT-P13 Associated With Loss of Response in Patients With Behçet's Disease
November 22nd 2017A recent case report, published in the European Journal of Rheumatology, showed that switching to biosimilar infliximab resulted in a rapid loss of efficacy in 3 patients with Behçet’s disease (BD), a chronic, relapsing, systemic vasculitis.
Report: Orphan Drugs Represent a Small Share of US Prescription Drug Spending
October 19th 2017While no one argues that orphan drugs that treat rare diseases can be expensive, the drugs’ reputation for being budget-busters is not borne out by a data presented in a recent report by Quintiles IMS Institute.
